Research Progress on Prevention and Treatment of Glucolipid Metabolic Disease with Integrated Traditional Chinese and Western Medicine

被引:0
|
作者
GUO Jiao
机构
[1] Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine
[2] Key Unit of Modulating Liver in Treating Hyperlipidemia SACM,Institute of Traditional Chinese Medicine Research Institute,Guangdong Pharmaceutical University
[3] Guangdong Key Laboratory of Metabolic Disease Prevention and Treatment of Traditional Chinese Medicine
基金
中国国家自然科学基金;
关键词
glucolipid metabolic disease; liver-based regulatory system for metabolic homeostasis; Tiao Gan(Liver) Qi Shu Hua Zhuo(modulating Gan; trigging key metabolic system to resolve pathogenic factors such as phlegm retention and dampness); Chinese medicine;
D O I
暂无
中图分类号
R58 [内分泌腺疾病及代谢病];
学科分类号
1002 ; 100201 ;
摘要
Hyperlipidemia,type 2 diabetes mellitus,nonalcoholic fatty liver and many other metabolic disorder are frequently co-existing in patients.In addition,these diseases are closely related in pathophysiological settings.However,increasing of the disease incidence,lacking of comprehensive prevention and control measurements against the key pathology point concomitant occurrence with the pattern of the single disease,single target therapy,that is leading therapeutic strategy for these metabolic disorders in the setting of Western medicine(WM).On the basis of the combination of the advantages of integrated Chinese medicine(CM) and WM,with unified understanding of such diseases,the new concept of glucolipid metabolic disease(GLMD) is introduced.In this new concept,disorders in glucose and lipid metabolism are recognized as the key trigger and major driving force for the progress of GLMD.The key points of pathology included dysfunction of neuronal-endocrine-immune system,insulin resistance,oxidative stress,inflammation and intestinal flora imbalance.In the core pathogenic perspective of CM,it can be explained as "Gan(Liver) Shi Shu Xie"(dysfunction of Gan in metabolism and emotion regulation) that will lead to the occurence/production of endogenous dampness and phlegm,blood stasis and turbid.This leads to the new concept of "Liver-based regulatory system for metabolic homeostasis" to be introduced further.The comprehensive prevention and control strategy "Tiao Gan Qi Shu Hua Zhuo"(modulating Gan,trigging key metabolic system to resolve pathogenic factors such as phlegm retention and dampness).Its representative formula Fufang Zhenzhu Tiaozhi Capsule(复方贞术调脂胶囊) is innovated under such rationales.Comment for some commonly-used CM GLMD therapeutic drugs was presented.High-level evidence-based and epidemiological and mechanism studies should be carried out to further interpret and explain of the scientific connotation of GLMD.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 50 条
  • [31] Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
    Xin Ding
    Xu He
    Bulang Tang
    Tian Lan
    Chinese Medicine, 19
  • [32] Research Progress of Traditional Chinese and Western Medicine on Gout Complicated with Diabetes Mellitus
    Guoqing ZHAO
    Lamei ZHOU
    Medicinal Plant, 2021, 12 (02) : 11 - 13
  • [33] Research Progress on Dialectical Treatment of Cold Coagulation Type Primary Dysmenorrhea of Traditional Chinese and Western Medicine
    Zhu, Huifang
    Wang, Dongjie
    Lu, Guifeng
    Sun, Hang
    Zhao, Yujing
    Niu, Lihua
    PROCEEDINGS OF THE 2016 2ND INTERNATIONAL CONFERENCE ON EDUCATION, SOCIAL SCIENCE, MANAGEMENT AND SPORTS (ICESSMS 2016), 2016, 92 : 1 - 4
  • [34] Integration of Traditional Chinese Medicine and Western Medicine in the Treatment of Knee Osteoarthritis: Research Progress on the Combination of Acupuncture and Diclofenac Sodium
    Li, Jingjing
    Zhang, Xiaoli
    Xie, Luojun
    Lou, Fei
    Shen, Jieru
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 199 - 203
  • [35] Progress and challenges in integrated traditional Chinese and western medicine in China from 2002 to 2021
    Zhou, Man-Ci
    Fei, Yu-Tong
    Lai, Xiao-Zhen
    Lan, Jian
    Liu, Bo
    Wang, Zhi-Wei
    Fang, Hai
    Liu, Jian-Ping
    Rong, Hong-Guo
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [36] Research progress on natural products from traditional Chinese medicine in treatment of Alzheimer's disease
    Gao, Jianjun
    Inagaki, Yoshinori
    Li, Xuan
    Kokudo, Norihiro
    Tang, Wei
    DRUG DISCOVERIES AND THERAPEUTICS, 2013, 7 (02): : 46 - 57
  • [37] Research progress on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer's disease
    Gao, Jianjun
    Inagaki, Yoshinori
    Liu, Yang
    INTRACTABLE & RARE DISEASES RESEARCH, 2013, 2 (01) : 3 - 10
  • [38] Research progress in the treatment of slow transit constipation by traditional Chinese medicine
    Wang, LiangFeng
    Wu, Fei
    Hong, YanLong
    Shen, Lan
    Zhao, LiJie
    Lin, Xiao
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 290
  • [39] Research progress on icariin, a traditional Chinese medicine extract, in the treatment of asthma
    Yuan, Jia-ying
    Tong, Zhi-ying
    Dong, Yu-chao
    Zhao, Jia-yi
    Shang, Yan
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2022, 50 (01) : 9 - 16
  • [40] Clinical practice guidelines for prevention and treatment of postoperative gastrointestinal disorder with Integrated Traditional Chinese and Western Medicine (2023)
    Xue, Jianjun
    Xu, Ziqing
    Wang, Qiang
    Hou, Huaijing
    Wei, Lili
    Zhang, Jie
    Zhao, Xiaohong
    Chen, Liping
    Ding, Fanfan
    Ma, Li
    Zhao, Yongqiang
    Wang, Yingbin
    Ma, Daqing
    Wang, Tianjun
    Liu, Renyu
    Gan, Tong J.
    Robinson, Nicky
    Frank, Yurasek
    Su, Fan
    Chi, Yongliang
    Yang, Dianhui
    Liu, Shujuan
    Cui, Suyang
    Wei, Yousong
    Chen, Zhiqiang
    Qin, You
    Cao, Lixing
    Chen, Guiping
    Shu, Kuanyong
    Xiao, Zhongqing
    Zhang, Hui
    Yu, Jianbo
    Hu, Zhiqian
    Cheng, Huakun
    Ma, Wuhua
    Liu, Guokai
    Wang, Xiuli
    Cao, Xinghua
    Gao, Ju
    Kong, Gaoyin
    Tao, Qing
    Wang, Baohua
    Wang, Junlu
    Li, Hong
    Lyu, Cuixia
    Zhang, Zhiming
    Li, Tianzuo
    Yang, Kehu
    JOURNAL OF EVIDENCE BASED MEDICINE, 2024, 17 (01) : 207 - 223